Differential effects of 5,7-dihydroxytryptamine-induced serotoninergic degeneration on 5-HT1A receptors and 5-HT uptake sites in the rat brain

Marco Gobbi, Maria Cristina Regondi, Maria Pompeiano, JosèMaria Palacios, Tiziana Mennini

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The time-course of 5,7-dihydroxytryptamine-induced lesions (2, 5 and 14 days after i.c.v. injection of 150 μg) and the effects of acute reserpine treatment (10 mg/kg, i.p., one or 5 days before scheduled death), were evaluated by autoradiography of [3H]paroxetine binding sites in the rat brain. Reserpine had no significant effect on [3H]paroxetine binding, indicating that the depletion of serotonin is not sufficient per se to alter the serotonin uptake sites in any region. Two days after the 5,7-dihydroxytryptamine lesion, [3H]paroxetine binding was already decreased in the majority of brain regions. In the caudate putamen these binding sites were significantly decreased only 14 days after the lesion, whereas the ventral tegmental area (or the enclosed median forebrain bundle), the dorsal raphe (mainly the ventral portion) and the median raphe maintained their high density of serotonin uptake sites even after 14 days. Results were similar using [3H]citalopram as ligand for the serotonin uptake sites, in the brains of rats lesioned 5 days before death; an exception was the ventral portion of the dorsal raphe, where there was a significant increase with [3H]paroxetine and a decrease with [3H]citalopram binding. In adjacent sections of the same brains we also measured [3H]8-OH-DPAT binding, confirming that it completely disappears in the dorsal raphe after the lesion. Thus, considering the extent of serotonin cell body degeneration, there appears to be a paradoxical mismatch between the excessive loss of [3H]8-OH-DPAT binding and the resistance of [3H]citalopram or [3H]paroxetine binding in the dorsal raphe, suggesting that the two binding sites may undergo adaptive regulation in surviving neurons.

Original languageEnglish
Pages (from-to)65-73
Number of pages9
JournalJournal of Chemical Neuroanatomy
Volume7
Issue number1-2
DOIs
Publication statusPublished - 1994

Fingerprint

5,7-Dihydroxytryptamine
Paroxetine
Receptor, Serotonin, 5-HT1A
Serotonin
Citalopram
Brain
8-Hydroxy-2-(di-n-propylamino)tetralin
Reserpine
Binding Sites
Medial Forebrain Bundle
Ventral Tegmental Area
Putamen
Autoradiography
Ligands
Neurons
Injections
Dorsal Raphe Nucleus

Keywords

  • Rat brain
  • Serotonin receptor
  • Serotonin uptake site

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience

Cite this

Differential effects of 5,7-dihydroxytryptamine-induced serotoninergic degeneration on 5-HT1A receptors and 5-HT uptake sites in the rat brain. / Gobbi, Marco; Regondi, Maria Cristina; Pompeiano, Maria; Palacios, JosèMaria; Mennini, Tiziana.

In: Journal of Chemical Neuroanatomy, Vol. 7, No. 1-2, 1994, p. 65-73.

Research output: Contribution to journalArticle

@article{30d487ed4347445f9c324649eb72983e,
title = "Differential effects of 5,7-dihydroxytryptamine-induced serotoninergic degeneration on 5-HT1A receptors and 5-HT uptake sites in the rat brain",
abstract = "The time-course of 5,7-dihydroxytryptamine-induced lesions (2, 5 and 14 days after i.c.v. injection of 150 μg) and the effects of acute reserpine treatment (10 mg/kg, i.p., one or 5 days before scheduled death), were evaluated by autoradiography of [3H]paroxetine binding sites in the rat brain. Reserpine had no significant effect on [3H]paroxetine binding, indicating that the depletion of serotonin is not sufficient per se to alter the serotonin uptake sites in any region. Two days after the 5,7-dihydroxytryptamine lesion, [3H]paroxetine binding was already decreased in the majority of brain regions. In the caudate putamen these binding sites were significantly decreased only 14 days after the lesion, whereas the ventral tegmental area (or the enclosed median forebrain bundle), the dorsal raphe (mainly the ventral portion) and the median raphe maintained their high density of serotonin uptake sites even after 14 days. Results were similar using [3H]citalopram as ligand for the serotonin uptake sites, in the brains of rats lesioned 5 days before death; an exception was the ventral portion of the dorsal raphe, where there was a significant increase with [3H]paroxetine and a decrease with [3H]citalopram binding. In adjacent sections of the same brains we also measured [3H]8-OH-DPAT binding, confirming that it completely disappears in the dorsal raphe after the lesion. Thus, considering the extent of serotonin cell body degeneration, there appears to be a paradoxical mismatch between the excessive loss of [3H]8-OH-DPAT binding and the resistance of [3H]citalopram or [3H]paroxetine binding in the dorsal raphe, suggesting that the two binding sites may undergo adaptive regulation in surviving neurons.",
keywords = "Rat brain, Serotonin receptor, Serotonin uptake site",
author = "Marco Gobbi and Regondi, {Maria Cristina} and Maria Pompeiano and Jos{\`e}Maria Palacios and Tiziana Mennini",
year = "1994",
doi = "10.1016/0891-0618(94)90008-6",
language = "English",
volume = "7",
pages = "65--73",
journal = "Journal of Chemical Neuroanatomy",
issn = "0891-0618",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Differential effects of 5,7-dihydroxytryptamine-induced serotoninergic degeneration on 5-HT1A receptors and 5-HT uptake sites in the rat brain

AU - Gobbi, Marco

AU - Regondi, Maria Cristina

AU - Pompeiano, Maria

AU - Palacios, JosèMaria

AU - Mennini, Tiziana

PY - 1994

Y1 - 1994

N2 - The time-course of 5,7-dihydroxytryptamine-induced lesions (2, 5 and 14 days after i.c.v. injection of 150 μg) and the effects of acute reserpine treatment (10 mg/kg, i.p., one or 5 days before scheduled death), were evaluated by autoradiography of [3H]paroxetine binding sites in the rat brain. Reserpine had no significant effect on [3H]paroxetine binding, indicating that the depletion of serotonin is not sufficient per se to alter the serotonin uptake sites in any region. Two days after the 5,7-dihydroxytryptamine lesion, [3H]paroxetine binding was already decreased in the majority of brain regions. In the caudate putamen these binding sites were significantly decreased only 14 days after the lesion, whereas the ventral tegmental area (or the enclosed median forebrain bundle), the dorsal raphe (mainly the ventral portion) and the median raphe maintained their high density of serotonin uptake sites even after 14 days. Results were similar using [3H]citalopram as ligand for the serotonin uptake sites, in the brains of rats lesioned 5 days before death; an exception was the ventral portion of the dorsal raphe, where there was a significant increase with [3H]paroxetine and a decrease with [3H]citalopram binding. In adjacent sections of the same brains we also measured [3H]8-OH-DPAT binding, confirming that it completely disappears in the dorsal raphe after the lesion. Thus, considering the extent of serotonin cell body degeneration, there appears to be a paradoxical mismatch between the excessive loss of [3H]8-OH-DPAT binding and the resistance of [3H]citalopram or [3H]paroxetine binding in the dorsal raphe, suggesting that the two binding sites may undergo adaptive regulation in surviving neurons.

AB - The time-course of 5,7-dihydroxytryptamine-induced lesions (2, 5 and 14 days after i.c.v. injection of 150 μg) and the effects of acute reserpine treatment (10 mg/kg, i.p., one or 5 days before scheduled death), were evaluated by autoradiography of [3H]paroxetine binding sites in the rat brain. Reserpine had no significant effect on [3H]paroxetine binding, indicating that the depletion of serotonin is not sufficient per se to alter the serotonin uptake sites in any region. Two days after the 5,7-dihydroxytryptamine lesion, [3H]paroxetine binding was already decreased in the majority of brain regions. In the caudate putamen these binding sites were significantly decreased only 14 days after the lesion, whereas the ventral tegmental area (or the enclosed median forebrain bundle), the dorsal raphe (mainly the ventral portion) and the median raphe maintained their high density of serotonin uptake sites even after 14 days. Results were similar using [3H]citalopram as ligand for the serotonin uptake sites, in the brains of rats lesioned 5 days before death; an exception was the ventral portion of the dorsal raphe, where there was a significant increase with [3H]paroxetine and a decrease with [3H]citalopram binding. In adjacent sections of the same brains we also measured [3H]8-OH-DPAT binding, confirming that it completely disappears in the dorsal raphe after the lesion. Thus, considering the extent of serotonin cell body degeneration, there appears to be a paradoxical mismatch between the excessive loss of [3H]8-OH-DPAT binding and the resistance of [3H]citalopram or [3H]paroxetine binding in the dorsal raphe, suggesting that the two binding sites may undergo adaptive regulation in surviving neurons.

KW - Rat brain

KW - Serotonin receptor

KW - Serotonin uptake site

UR - http://www.scopus.com/inward/record.url?scp=0027931561&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027931561&partnerID=8YFLogxK

U2 - 10.1016/0891-0618(94)90008-6

DO - 10.1016/0891-0618(94)90008-6

M3 - Article

VL - 7

SP - 65

EP - 73

JO - Journal of Chemical Neuroanatomy

JF - Journal of Chemical Neuroanatomy

SN - 0891-0618

IS - 1-2

ER -